Case 2: A 28-year-old female with ALK-positive non–small cell lung cancer presents with severe respiratory compromise due to extensive mediastinal disease and high-output chylothorax (>1 L/day) refractory to conventional therapy. This evidence concerns the gene ALK and lung cancer.